» Articles » PMID: 11584064

Familial Multiple Myeloma: a Family Study and Review of the Literature

Overview
Specialty Oncology
Date 2001 Oct 5
PMID 11584064
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The etiology of multiple myeloma (MM) remains obscure, although reports of familial clustering have implicated both a host susceptibility factor and environmental effects. Here we describe the medical histories of members of a family prone to MM.

Methods: We developed a pedigree for an MM-prone family by using information obtained from a questionnaire. Protein immunoelectrophoresis of serum and urine from the proband and from 19 family members was performed to detect monoclonal immunoproteins. Peripheral blood obtained from the proband and from five relatives was subjected to standard cytogenetic studies to detect constitutional chromosomal abnormalities. Multifluor-fluorescence in situ hybridization (M-FISH) and standard FISH studies were performed on peripheral blood from the proband and from two other affected living relatives to determine their karyotypes and to detect clonal chromosomal abnormalities frequently seen in patients with MM.

Results: Within this family, a sibship of seven included three individuals (including the proband) with histologically verified MM and two individuals with a monoclonal gammopathy of unknown significance (MGUS), as determined by immunoelectrophoresis of serum and urine. This family also had members with acute lymphocytic leukemia, malignant melanoma, and prostate cancer. In the family members tested, we detected no constitutional chromosomal abnormality. None of the three individuals analyzed by FISH had a deletion of the retinoblastoma (Rb-1) locus, which is frequently deleted in patients with MM, and only one (the proband) had a translocation involving chromosomes 11 and 14, a clonal abnormality commonly seen in MM.

Conclusion: The study of familial MM may provide insights into the pathogenesis and, ultimately, the control and prevention of MM and related disorders.

Citing Articles

Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility.

Elbadry M, Abdelkreem E, Tawfeek A, Seo G, Aziz S Ann Hematol. 2025; .

PMID: 40047910 DOI: 10.1007/s00277-025-06257-6.


A Case of Concomitant Multiple Myeloma and Cirrhosis.

Hindosh Z, Potharaju A Cureus. 2023; 15(8):e44286.

PMID: 37779736 PMC: 10533365. DOI: 10.7759/cureus.44286.


Interruption of aberrant chromatin looping is required for regenerating RB1 function and suppressing tumorigenesis.

Wen X, Ding T, Li F, Fan J, Fan X, Jia R Commun Biol. 2022; 5(1):1036.

PMID: 36175480 PMC: 9522773. DOI: 10.1038/s42003-022-04007-2.


Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study.

Langseth O, Myklebust T, Johannesen T, Hjertner O, Waage A Eur J Haematol. 2022; 108(6):486-492.

PMID: 35184337 PMC: 9310738. DOI: 10.1111/ejh.13757.


Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis.

Visram A, Vachon C, Baughn L, Larson D, Smadbeck J, Dispenzieri A Leukemia. 2021; 36(4):1058-1065.

PMID: 34764424 DOI: 10.1038/s41375-021-01454-4.